Global Surgical Robotics Market is Expected to be Led by New Product Launches and Rise in Number of Medical Surgeries: Ken Research December 2017 | Global News
At least 7 surgical robots are expected to be commercially launched in the US and European markets by 2021. As of 2016, only 14% of the 4 million applicable soft tissue surgeries were performed using robotic surgical technology in the US and the penetration of surgical robots was even lower in other developed countries. This highlights enormous potential for robot-assisted surgeries going forward.
The number of total hip replacement procedures in the US was approximately 400,000 each year, and is expected to increase threefold by 2030. The demand for total-knee replacements is expected to increase more than six fold by 2030 from current 500,000 each year. Within five years, 1/3rd of all surgeries in the US, more than double the current levels, are expected to be performed with robotic systems. Countries such as Germany, France, Portugal, Belgium, Sweden, Denmark, Netherlands, Italy and the UK spent between 7-9% of their GDP on healthcare every year. Approximately, 160,000 total hip and knee replacement procedures are performed each year in the UK. In France, more than 90,000 total knee arthroplasty procedures are performed every year. More than 90,000 total/partial hip replacement procedures and over 70,000 total knee replacement procedures are performed each year in Germany.
1